Boston Scientific (BSX) PT Lowered to $115 but RBC Capital Sees Stock Reaction as a Buying Opportunity
Tweet Send to a Friend
RBC Capital analyst Shagun Singh lowered the price target on Boston Scientific (NYSE: BSX) to $115.00 (from $130.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
